InvestorsHub Logo
Followers 481
Posts 60441
Boards Moderated 18
Alias Born 09/20/2001

Re: None

Wednesday, 06/03/2020 8:30:26 AM

Wednesday, June 03, 2020 8:30:26 AM

Post# of 158
4/23/20 - Volition Files Patent for Nu.Q(TM) COVID-19 Triage Test and Commences Proof of Concept Studies


AUSTIN, Texas, April 23, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced that it is actively developing a COVID-19 triage test aiming to predict the likelihood that an individual who is COVID-19 positive will develop complications and severe disease, using its propriety Nu.QTM platform. The goal of the test is to provide early insight into which patients may require higher levels of monitoring including hospitalization and critical care resources, versus those who will not develop serious symptoms. Preliminary studies of patients with COVID-19 infection are now underway in hospitals in Belgium and Germany with results expected this quarter.



Full PR:
https://finance.yahoo.com/news/volition-files-patent-nu-q-123000672.html





Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VNRX News